17444 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 

certification of those accredited 

Canadian laboratories will continue 

under DOT authority. The responsibility 

for conducting quarterly performance 

testing plus periodic on-site inspections 

of those LAPSA-accredited laboratories 

was transferred to the U.S. HHS, with 

the HHS’ NLCP contractor continuing to 

have an active role in the performance 

testing and laboratory inspection 

processes. Other Canadian laboratories 

wishing to be considered for the NLCP 

may apply directly to the NLCP 

contractor just as U.S. laboratories do. 

Upon finding a Canadian laboratory to 

be qualified, HHS will recommend that 

DOT certify the laboratory (Federal 

Register, July 16, 1996) as meeting the 

minimum standards of the Mandatory 

Guidelines published in the Federal 

Register on April 30, 2010 (75 FR 

22809). After receiving DOT 

certification, the laboratory will be 

included in the monthly list of HHScertified laboratories and participate in 

the NLCP certification maintenance 

program. 

Janine Denis Cook, 

Chemist Division of Workplace Programs, 

Center for Substance Abuse Prevention, 

SAMHSA. 

[FR Doc. 2015–07423 Filed 3–31–15; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2015–0001] 

Proposed Substances To Be Evaluated 

for Set 29 Toxicological Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for comments on the 

proposed substances to be evaluated for 

Set 29 toxicological profiles. 

SUMMARY: ATSDR is initiating the 

development of its 29th set of 

toxicological profiles (CERCLA Set 29). 

This notice announces the list of 

proposed substances that will be 

evaluated for CERCLA Set 29 

toxicological profile development. 

ATSDR’s Division of Toxicology and 

Human Health Sciences is soliciting 

public nominations from the list of 

proposed substances to be evaluated for 

toxicological profile development. 

ATSDR also will consider the 

nomination of any additional, nonCERCLA substances that may have 

public health implications, on the basis 

of ATSDR’s authority to prepare 

toxicological profiles for substances not 

found at sites on the National Priorities 

List. The agency will do so in order to 

‘‘. . . establish and maintain inventory 

of literature, research, and studies on 

the health effects of toxic substances’’ 

under CERCLA Section 104(i)(1)(B), to 

respond to requests for consultation 

under section 104(i)(4), and to support 

the site-specific response actions 

conducted by ATSDR, as otherwise 

necessary. 

DATES: Nominations from the Substance 

Priority List and/or additional 

substances must be submitted within 30 

days of the publication of this notice. 

ADDRESSES: You may submit 

nominations, identified by Docket No. 

ATSDR–2015–0001, by any of the 

following methods: 

*Internet: Access the Federal 

eRulemaking portal at http://

www.regulations.gov. Follow the 

instructions for submitting comments. 

*Mail: Division of Toxicology and 

Human Health Sciences, 1600 Clifton 

Rd. NE., MS F–57, Atlanta, Ga., 30333. 

Instructions: All submissions must 

include the agency name and docket 

number for this notice. All relevant 

comments will be posted without 

change. This means that no confidential 

business information or other 

confidential information should be 

submitted in response to this notice. 

Refer to the section Submission of 

Nominations (below) for the specific 

information required. 

FOR FURTHER INFORMATION CONTACT: For 

further information, please contact 

Commander Jessilynn B. Taylor, 

Division of Toxicology and Human 

Health Sciences, 1600 Clifton Rd. NE., 

MS F–57, Atlanta, Ga., 30333, Email: 

tpcandidatecomments@cdc.gov; phone: 

1–800–232–4636. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act of 1986 (SARA) [42 

U.S.C. 9601 et seq.] amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) [42 

U.S.C. 9601 et seq.] by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) with regard to hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List (NPL). Among these 

statutory requirements is a mandate for 

the Administrator of ATSDR to prepare 

toxicological profiles for each substance 

included on the Priority List of 

Hazardous Substances. This list 

identifies 275 hazardous substances that 

ATSDR and EPA have determined pose 

the most significant current potential 

threat to human health. The availability 

of the revised list of the 275 priority 

substances was announced in the 

Federal Register on May 28, 2014 (79 

FR 30613). For prior versions of the list 

of substances, see Federal Register 

notices dated April 17, 1987 (52 FR 

12866); October 20, 1988 (53 FR 41280); 

October 26, 1989 (54 FR 43619); October 

17,1990 (55 FR 42067); October 17, 1991 

(56 FR 52166); October 28, 1992 (57 FR 

48801); February 28, 1994 (59 FR 9486); 

April 29, 1996 (61 FR 18744); November 

17, 1997 (62 FR 61332); October 21, 

1999 (64 FR 56792); October 25, 2001 

(66 FR 54014); November 7, 2003 (68 FR 

63098); December 7, 2005 (70 FR 

72840); and March 6, 2008 (73 FR 

12178); November 3, 2011 (76 FR 

68193). 

Substances To Be Evaluated for Set 29 

Toxicological Profiles 

Each year, ATSDR develops a list of 

substances to be considered for 

toxicological profile development. The 

Set 29 nomination process includes 

consideration of all substances on 

ATSDR’s Priority List of Hazardous 

Substances, also known as the 

Substance Priority List (SPL), as well as 

other substances nominated by the 

public. The 275 substances on the SPL 

will be considered for Set 29 

Toxicological Profile development. This 

list may be found at the following Web 

site: www.atsdr.cdc.gov/SPL. 

Submission of Nominations for the 

Evaluation of Set 29 Proposed 

Substances 

Today’s notice invites voluntary 

public nominations for substances 

included on the SPL and for substances 

not listed on the SPL. All nominations 

should include the full name of the 

nominator, affiliation, and email 

address. When nominating a non-SPL 

substance, please include the rationale 

for the nomination. Please note that 

email addresses will not be posted on 

regulations.gov. 

ATSDR will evaluate all data and 

information associated with nominated 

substances and will determine the final 

list of substances to be chosen for 

toxicological profile development. 

Substances will be chosen according to 

ATSDR’s specific guidelines for 

selection. These guidelines can be found 

in the Selection Criteria announced in 

the Federal Register on May 7, 1993 (58 

FR 27286–27287). A hard copy of the 

Selection Criteria is available upon 

request or may be accessed at: http://

www.atsdr.cdc.gov/toxprofiles/

guidance/criteria_for_selecting_tp_

support.pdf. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 17445 

Please ensure that your comments are 

submitted within the specified 

nomination period. Nominations 

received after the closing date will be 

marked as late and may be considered 

only if time and resources permit. 

Sascha Chaney, 

Acting Director, Office of Policy, Planning 

and Evaluation National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2015–07437 Filed 3–31–15; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Generic Clearance for Grant 

Reviewer Recruitment Form. 

OMB No.: New. 

Description: This notice announces 

that the Administration for Children 

and Families intends to submit the 

proposed Information Collection 

Request (Generic ICR): Generic 

Clearance for Grant Reviewer 

Application Form under the Paperwork 

Reduction (PRA) (44 U.S.C. 3501 et. 

seq.). Comments on specific aspects for 

the proposed information collection are 

being solicited. 

This request is for approval of a plan 

for conducting more than one 

information collection that is very 

similar, voluntary, low-burden and 

uncontroversial. Information collections 

under this generic clearance will be in 

compliance with U.S. Department of 

Health and Humans Services’ Grants 

Policy Directive 2.04 ‘‘Awarding 

Grants’’, and the Awarding Agency 

Grants Administration Manual, Chapter 

2.04C ‘‘Objective Review of Grant 

Applications. These forms will be used 

to select reviewers who will participate 

in the grant review process for the 

purpose of selecting successful 

applications. 

Respondents: Grant Reviewer 

Candidates. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Recruitment Form ............................................................................................ 1,500 1 0.5 750 

Estimated Total Annual Burden 

Hours: 750 Hours. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Planning, Research and Evaluation, 370 

L’Enfant Promenade SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. Email address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Email: OIRA_

SUBMISSION@OMB.EOP.GOV, Attn: 

Desk Officer for the Administration for 

Children and Families. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2015–07352 Filed 3–31–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0025] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Animal Food 

Labeling; Declaration of Certifiable 

Color Additives 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

burden hours associated with the 

animal food industry declaring the 

presence of certified and noncertified 

color additives in their animal food 

products on the animal food label. 

DATES: Submit either electronic or 

written comments on the collection of 

information by June 1, 2015. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http://

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes Agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

Agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

mstockstill on DSK4VPTVN1PROD with NOTICES